Trial on Education And Clinical Outcomes for Home PD Patients (TEACH)
TEACH
1 other identifier
interventional
104
1 country
6
Brief Summary
Since the emergence of home peritoneal dialysis as an alternative to in-center hemodialysis for chronic renal replacement therapy in the late 1970s, the percentage of dialysis patients on PD has continued to decrease each year. There have been a growing concern and research on patient and technique survival of peritoneal dialysis versus hemodialysis to find influential factors for better clinical outcomes. Meanwhile, technique failure rates were significantly higher in small centers treating less than twenty five PD patients. And there was a result for better technique survival after the second year, among the patients trained at the BREC(Baxter Renal Education Center). Better technique survival in large centers can be assumed with not only their more experience with patient management but also their educational infrastructure compared to small-sized centers. Throughout our experiences in the last 30 years, we have recognized that a major element of PD program is patient training, however few data are available in terms of the relationship between PD training and treatment outcome and mostly are retrospective and non-randomized. Moreover, the technique survival and patient survival were analyzed with no significant difference. From the insight, we decided to study prospectively to evaluate the efficacy of well-structured education program in terms of various patient outcomes in incident patients on PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2010
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2010
CompletedFirst Posted
Study publicly available on registry
September 17, 2010
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedApril 14, 2016
April 1, 2016
4.6 years
September 16, 2010
April 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exit site infection
24 months
Secondary Outcomes (23)
time to the first peritonitis
24 months
Number of ESIs per patient-month
24 months
Days of hospitalization per year
24 months
Systolic pressure and diastolic pressure measured at every visit
24 months
Average number of antihypertensive medications
24 months
- +18 more secondary outcomes
Study Arms (2)
Conventional training group
NO INTERVENTIONin-center conventional training programs + two home visits
Intensive training group
EXPERIMENTALin-center conventional training programs + an extra structured patient home visits repeatedly and regularly
Interventions
an extra structured patient centric training program on PD technique and diet according to the developed training curriculum
Eligibility Criteria
You may qualify if:
- Incident patients who have PD catheter insertion for starting PD with Baxter solutions
- \> 20 yr of age
You may not qualify if:
- Patients who are likely to receive kidney transplant or shift to hemodialysis within the following 1 year
- Patients diagnosed with acute inflammatory disease for the past three months
- Patients currently diagnosed with chronic inflammatory disease
- Currently pregnant or breastfeeding
- Patients who are involved in other clinical trial within 30 days prior to enrollment
- Patients who are currently hospitalized in care facilities such as nursing home, etc., or those who are expected to be hospitalized for the duration of the clinical test
- Patients who cannot perform PD by themselves
- Patients considered by the person in charge of the clinical test to have difficulty in participating in this clinical test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kook-Hwan Ohlead
- Baxter Healthcare Corporationcollaborator
Study Sites (6)
Wonkwang University, Sanbon Medical Center
Gunpo, Gyeonggi-do, South Korea
Hallym University Sacred Hospital Puyngchon
Anyang, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Eulji Medical Center
Seoul, South Korea
Hallym University Sacred Hospital Gangdong
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kook-Hwan Oh, M.D., PhD
Seoul National University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 16, 2010
First Posted
September 17, 2010
Study Start
December 1, 2010
Primary Completion
July 1, 2015
Study Completion
March 1, 2016
Last Updated
April 14, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share